Literature DB >> 17699509

BK virus nephropathy and kidney transplantation.

Daniel L Bohl1, Daniel C Brennan.   

Abstract

Nephropathy from BK virus (BKV) infection is an evolving challenge in kidney transplant recipients. It is the consequence of modern potent immunosuppression aimed at reducing acute rejection and improving allograft survival. Untreated BKV infections lead to kidney allograft dysfunction or loss. Decreased immunosuppression is the principle treatment but predisposes to acute and chronic rejection. Screening protocols for early detection and prevention of symptomatic BKV nephropathy have improved outcomes. Although no approved antiviral drug is available, leflunomide, cidofovir, quinolones, and intravenous Ig have been used. Retransplantation after BKV nephropathy has been successful.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17699509     DOI： 10.2215/CJN.00920207

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


  57 in total

1.  Inhibitory interactions between BK and JC virus among kidney transplant recipients.

Authors:  Xingxing S Cheng; Daniel L Bohl; Gregory A Storch; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Eugene O Major; Parmjeet Randhawa; Karen L Hardinger; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Comparison of anti-reflux mechanism between Double-J-Stent and standart Double-J-Stent use for risk of BK nephropathy and urinary tract Infection in kidney transplantation.

Authors:  Nurettin Ay; Mehmet Veysi Bahadır; Melih Anıl; Vahhac Alp; Şafak Kaya; Utkan Sevük; Mesut Gül; Ramazan Danış
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.

Authors:  Melissa Krystel-Whittemore; Ellen T McCarthy; Ivan Damjanov; Timothy A Fields
Journal:  BMJ Case Rep       Date:  2015-08-28

4.  Mining the human urine proteome for monitoring renal transplant injury.

Authors:  Tara K Sigdel; Yuqian Gao; Jintang He; Anyou Wang; Carrie D Nicora; Thomas L Fillmore; Tujin Shi; Bobbie-Jo Webb-Robertson; Richard D Smith; Wei-Jun Qian; Oscar Salvatierra; David G Camp; Minnie M Sarwal
Journal:  Kidney Int       Date:  2016-03-04       Impact factor: 10.612

5.  Replication of oral BK virus in human salivary gland cells.

Authors:  Raquel Burger-Calderon; Victoria Madden; Ryan A Hallett; Aaron D Gingerich; Volker Nickeleit; Jennifer Webster-Cyriaque
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  BK Virus-Associated Nephropathy in Kidney Transplant Recipients.

Authors:  Jorge C Garces
Journal:  Ochsner J       Date:  2010

7.  Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.

Authors:  J A Albrecht; Y Dong; J Wang; C Breeden; A B Farris; A E Lukacher; K A Newell
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

Review 8.  Mechanisms of BK virus infection of renal cells and therapeutic implications.

Authors:  Christiane Mbianda; Ashraf El-Meanawy; Andrey Sorokin
Journal:  J Clin Virol       Date:  2015-08-06       Impact factor: 3.168

9.  Relationships among injury, fibrosis, and time in human kidney transplants.

Authors:  Jeffery M Venner; Konrad S Famulski; Jeff Reeve; Jessica Chang; Philip F Halloran
Journal:  JCI Insight       Date:  2016-01-21

10.  High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses.

Authors:  Edward C Goodwin; Walter J Atwood; Daniel DiMaio
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.